
دارونو
صندوق س صنايع مفيد5-بخشي
Adjusted Price Chart of دارونو and دارونو Signal Trend
سود 3 Months :
Traders' comments on price دارونو
Who made the most profit from دارونو?
سیگنالهای دارونو
Filter
Signal Type
Trader Type
Time Frame
نوع پیام
BFM Investment Fund. A. The useful marketing of 5.000 million shares purchased on 104/04/10 and currently accounts for 2.906 % of Darono's shares in its joint portfolio.
ETF has bought 5,000 million Darono's shares on 10/4/10/10 and currently accounts for 65.68 % of Darono's shares in its corporate portfolio.

وارن بافت
خرید های متوالی صندوق مفید در #دارونو

صندوق سرمایه گذاری ثابت حامی یکم مفید
The fixed -use Fundy Fund bought 10,000 million Dono shares on 14/03/17 and currently accounts for 2.666 % of Darono's shares in its equity portfolio.

حمید کوشکی(تحلیل کاربردی)
🔎 Weight loss of Tipico and Dafara; Buy Designing 💊 🗓 Review #Pharmaceutical Department Portfolio #Darreno to May 1404 انی The land has bought 78 billion tomans in the last month and has sold 64 billion tomans. 🟢 Most of the shopping: Dezagress - Valley The Most Best Sales: Tipico - Dafara The stock weight increased by 1.1 percent compared to the previous month and the deposit weight decreased by 5.2 percent compared to the previous month. 🌐 Finder

وارن بافت
Purchase of successive boxes in #placebo

وارن بافت
Useful daily purchases in the #placebo box

حمید کوشکی(تحلیل کاربردی)
📊 Comparison #Funds #Division_Dear in May 1404 💊 The best performance in May was the #Darono Fund, which had the best growth with+ 9.3 % but was 4 % weaker than the drug index. The second degree belongs to the #Farmani Fund with+ 6.8 %. The lowest efficiency among the above funds belongs to the #Pharmacan Fund, which is+ 5.6 % and has done better than the drug index of 7.5. All drug departments have been weaker than the drug index. ⚖️ The difference between the best performance of the box (placebo) and the weaker performance (Pharmaccian) is 3.7 %. 🌐 Finder

وارن بافت
Daily Purchases of Useful Funds in #Dono

وارن بافت
Useful Buyer Fund
Disclaimer
Any content and materials included in Sahmeto's website and official communication channels are a compilation of personal opinions and analyses and are not binding. They do not constitute any recommendation for buying, selling, entering or exiting the stock market and cryptocurrency market. Also, all news and analyses included in the website and channels are merely republished information from official and unofficial domestic and foreign sources, and it is obvious that users of the said content are responsible for following up and ensuring the authenticity and accuracy of the materials. Therefore, while disclaiming responsibility, it is declared that the responsibility for any decision-making, action, and potential profit and loss in the capital market and cryptocurrency market lies with the trader.